A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer

被引:0
|
作者
Ava Kwong
L. P. Wong
H. N. Wong
F. B. F. Law
E. K. O. Ng
Y. H. Tang
W. K. Chan
L. S. Ho
K. H. Kwan
M. Poon
T. T. Wong
F. C. S. Leung
S. W. W. Chan
M. W. L. Ying
E. S. K. Ma
J. M. Ford
机构
[1] The University of Hong Kong,Division of Breast Surgery, Queen Mary and Tung Wah Hospital
[2] Hong Kong Sanatorium and Hospital,Department of Molecular Pathology
[3] Hong Kong Sanatorium and Hospital,Department of Pathology
[4] Hong Kong Sanatorium and Hospital,Department of Surgery
[5] Princess Margaret Hospital,The Hong Kong Hereditary and High Risk Breast Cancer Programme
[6] Tuen Mun Hospital,undefined
[7] Queen Elizabeth Hospital,undefined
[8] Pamela Youde Nethersole Hospital,undefined
[9] United Christian Hospital,undefined
[10] Kwong Wah Hospital,undefined
[11] Stanford University School of Medicine,undefined
[12] The Hong Kong Hereditary Breast Cancer Family Registry,undefined
来源
关键词
BRCA Mutation; Male Breast Cancer; Recurrent Mutation; Male Breast Cancer Patient; Deleterious BRCA;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:683 / 686
页数:3
相关论文
共 50 条
  • [31] PARP inhibition with BMN 673 in ovarian and breast cancer patients with deleterious mutations of BRCA1 and BRCA2
    Ramanathan, R.
    Wainberg, Z.
    Mina, L.
    Byers, L.
    Chugh, R.
    Zhang, C.
    Henshaw, J.
    Dorr, A.
    de Bono, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S13 - S13
  • [32] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Alhuqail, Al-Joharah
    Alzahrani, Areej
    Almubarak, Hannah
    Al-Qadheeb, Sarah
    Alghofaili, Lamyaa
    Almoghrabi, Nisreen
    Alhussaini, Hamed
    Park, Ben Ho
    Colak, Dilek
    Karakas, Bedri
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (03) : 695 - 702
  • [33] Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients Finding Founder Mutations
    Choi, Min Chul
    Heo, Jin-Hyung
    Jang, Ja-Hyun
    Jung, Sang Geun
    Park, Hyun
    Joo, Won Duk
    Lee, Chan
    Lee, Je Ho
    Lee, Jun Mo
    Hwang, Yoon Young
    Kim, Seung Jo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (08) : 1386 - 1391
  • [34] Three novel BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia
    Levanat, Sonja
    Musani, Vesna
    Cvok, Mirela Levacic
    Susac, Ilona
    Sabol, Maja
    Ozretic, Petar
    Car, Diana
    Eljuga, Domagoj
    Eljuga, Ljerka
    Eljuga, Damir
    GENE, 2012, 498 (02) : 169 - 176
  • [35] Identification of a founder BRCA2 mutation in Sardinian breast cancer families
    Monne, Maria
    Piras, Giovanna
    Fancello, Patrizia
    Santona, Maria Cristina
    Uras, Antonella
    Landriscina, Gennaro
    Mastio, Giuseppe
    Gabbas, Attilio
    FAMILIAL CANCER, 2007, 6 (01) : 73 - 79
  • [36] Identification of a founder BRCA2 mutation in Sardinian breast cancer families
    Maria Monne
    Giovanna Piras
    Patrizia Fancello
    Maria Cristina Santona
    Antonella Uras
    Gennaro Landriscina
    Giuseppe Mastio
    Attilio Gabbas
    Familial Cancer, 2007, 6 : 73 - 79
  • [37] BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Buerkle, Bernd
    Tempfer, Clemens
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 359 - 359
  • [38] Founder BRCA1 Mutations and Two Novel Germline BRCA2 Mutations in Breast and/or Ovarian Cancer Families from North-Eastern Poland
    van der Looij, Marco
    Wysocka, Barbara
    Brozek, Izabela
    Jassem, Jacek
    Limon, Janusz
    Olah, Edith
    HUMAN MUTATION, 2000, 15 (05)
  • [39] Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan
    Liede, A
    Malik, IA
    Aziz, Z
    de los Rios, P
    Kwan, E
    Narod, SA
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (03) : 595 - 606
  • [40] Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families
    Giannini, Giuseppe
    Capalbo, Carlo
    Ristori, Elisabetta
    Ricevuto, Enrico
    Sidoni, Tina
    Buffone, Amelia
    Cortesi, Enrico
    Marchetti, Paolo
    Scambia, Giovanni
    Tomao, Silverio
    Rinaldi, Christian
    Zani, Massimo
    Ferraro, Sergio
    Frati, Luigi
    Screpanti, Isabella
    Gulino, Alberto
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (01) : 83 - 91